About lab
One published Lab
Build with this Lab. Run it anywhere.
Use the same immutable release locally or through managed cloud execution, with its exact version and provenance preserved.
Preparing exact examples…
Walsh2014 - Inhibition kinetics of DAPT onAPP Cleavage This model is described in the article: Are improper kinetic models hampering drug development? It can be used to explore dose-response dynamics and compare treatment scenarios across conditions.
Manifest
{
"io": {
"inputs": [
{
"name": "dapt_inhibitor_concentration",
"label": "Dapt Inhibitor Concentration",
"maps_to": "pharmacology_sbml_walsh2014_inhibition_kinetics_of_dapt_on_app_cle_biomd0000000617_model.dapt_inhibitor_concentration"
},
{
"name": "substrate_concentration",
"label": "Substrate Concentration",
"maps_to": "pharmacology_sbml_walsh2014_inhibition_kinetics_of_dapt_on_app_cle_biomd0000000617_model.substrate_concentration"
},
{
"name": "cleavage_state",
"label": "Cleavage State",
"maps_to": "pharmacology_sbml_walsh2014_inhibition_kinetics_of_dapt_on_app_cle_biomd0000000617_model.cleavage_state"
},
{
"name": "cleavage_vmax_1",
"label": "Cleavage VMAX 1",
"maps_to": "pharmacology_sbml_walsh2014_inhibition_kinetics_of_dapt_on_app_cle_biomd0000000617_model.cleavage_vmax_1"
},
{
"name": "cleavage_vmax_2",
"label": "Cleavage VMAX 2",
"maps_to": "pharmacology_sbml_walsh2014_inhibition_kinetics_of_dapt_on_app_cle_biomd0000000617_model.cleavage_vmax_2"
}
],
"outputs": [
{
"name": "state",
"label": "Tracked source state",
"maps_to": "pharmacology_sbml_walsh2014_inhibition_kinetics_of_dapt_on_app_cle_biomd0000000617_model.state"
},
{
"name": "summary",
"label": "Simulation summary",
"maps_to": "pharmacology_sbml_walsh2014_inhibition_kinetics_of_dapt_on_app_cle_biomd0000000617_model.summary"
},
{
"name": "species_labels",
"label": "Observable labels",
"maps_to": "pharmacology_sbml_walsh2014_inhibition_kinetics_of_dapt_on_app_cle_biomd0000000617_model.species_labels"
},
{
"name": "app_cleavage_state",
"label": "APP Cleavage State",
"maps_to": "pharmacology_sbml_walsh2014_inhibition_kinetics_of_dapt_on_app_cle_biomd0000000617_model.app_cleavage_state"
}
]
},
"tags": [
"pharmacology",
"neuroscience",
"enzyme-inhibition",
"amyloid",
"sbml",
"tellurium",
"faithful",
"biomodels_ebi"
],
"title": "Walsh2014 - Inhibition kinetics of DAPT on APP Cleavage Lab",
"models": [
{
"path": "models/core",
"alias": "pharmacology_sbml_walsh2014_inhibition_kinetics_of_dapt_on_app_cle_biomd0000000617_model",
"parameters": {
"model_path": "data/BIOMD0000000617.xml",
"integration_step": 0.2
}
},
{
"path": "models/visualisation",
"alias": "visualisation"
}
],
"wiring": [
{
"to": [
"visualisation.pharmacology_sbml_walsh2014_inhibition_kinetics_of_dapt_on_app_cle_biomd0000000617_model_state"
],
"from": "pharmacology_sbml_walsh2014_inhibition_kinetics_of_dapt_on_app_cle_biomd0000000617_model.state"
},
{
"to": [
"visualisation.pharmacology_sbml_walsh2014_inhibition_kinetics_of_dapt_on_app_cle_biomd0000000617_model_summary"
],
"from": "pharmacology_sbml_walsh2014_inhibition_kinetics_of_dapt_on_app_cle_biomd0000000617_model.summary"
},
{
"to": [
"visualisation.pharmacology_sbml_walsh2014_inhibition_kinetics_of_dapt_on_app_cle_biomd0000000617_model_species_labels"
],
"from": "pharmacology_sbml_walsh2014_inhibition_kinetics_of_dapt_on_app_cle_biomd0000000617_model.species_labels"
}
],
"package": "walsh2014-dapt-app-cleavage",
"runtime": {
"duration": 60,
"initial_inputs": {},
"communication_step": 2
},
"version": "1.0.0",
"description": "Walsh2014 - Inhibition kinetics of DAPT onAPP Cleavage This model is described in the article: Are improper kinetic models hampering drug development? It can be used to explore dose-response dynamics and compare treatment scenarios across conditions.",
"schema_version": "2.0"
}Runtime
Duration60
Comms Step2
Runs
Total0
Completed0
Failed0
Metadata
Packagewalsh2014-dapt-app-cleavage
Created2026-05-16
Updated2026-06-13
pharmacologyneuroscienceenzyme-inhibitionamyloidsbmltelluriumfaithfulbiomodels_ebivisualisationother